Mitigating the transmission of infection and death due to SARS-CoV-2 through non-pharmaceutical interventions and repurposing drugs

C Mondal, D Adak, A Majumder, N Bairagi - ISA transactions, 2022 - Elsevier
… As SARS-CoV-2 is a novel virus, every individual is assumed to be susceptible to this virus.
… representation reflects the usual coronavirus infection management protocol followed in …

[HTML][HTML] Biomarkers of COVID-19 and technologies to combat SARS-CoV-2

L Zhang, H Guo - Advances in Biomarker Sciences and Technology, 2020 - Elsevier
… way to detect the novel coronavirus, named SARS-CoV-2, and … prevention are the vital keys
to management of COVID-19, … known and emerging biomarkers for SARS-CoV-2 detection, …

SARS-CoV-2 infection and oral health: therapeutic opportunities and challenges

CJ Coke, B Davison, N Fields, J Fletcher… - Journal of Clinical …, 2021 - mdpi.com
… Finally, this review is a valuable resource for the management of oral hygiene and reduction
… -2 virus has proven to be challenging in the pharmaceutical pursuit of a successful drug for …

Potential therapeutic targets and promising drugs for combating SARSCoV‐2

H Zhou, Y Fang, T Xu, WJ Ni, AZ Shen… - British Journal of …, 2020 - Wiley Online Library
… , and pathogenic mechanisms of SARSCoV‐2. Based on this … based on these targets
for treating SARSCoV‐2. This review will … into clinical applications for combating SARSCoV‐2. …

An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection

A Safarchi, S Fatima, Z Ayati, F Vafaee - Cell & Bioscience, 2021 - Springer
The ongoing pandemic of coronavirus disease 2019 (COVID-19) has made a serious public
health and economic crisis worldwide which united global efforts to develop rapid, precise, …

Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa

E Margolin, WA Burgers, ED Sturrock… - Nature Reviews …, 2020 - nature.com
management of tuberculosis, with fewer diagnostic platforms being available as a result of
increased SARS-CoV… , including MERS-CoV, and Inovio Pharmaceuticals (USA) have already …

Mechanistic modeling of SARSCoV‐2 and other infectious diseases and the effects of therapeutics

AS Perelson, R Ke - Clinical Pharmacology & Therapeutics, 2021 - Wiley Online Library
… acute respiratory syndrome coronavirus 2 (SARS-CoV-2), … these models towards understanding
SARS-CoV-2 infection … and pharmaceutical interventions of the coronavirus disease …

The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories

Y Liu, C Morgenstern, J Kelly, R Lowe, M Jit - BMC medicine, 2021 - Springer
pharmaceutical interventions (NPIs) are used to reduce transmission of SARS coronavirus 2
(SARS-CoV-2) that causes coronavirus … health system actions on SARS-CoV-2 transmission …

[HTML][HTML] Inflammatory bowel disease: Clinical diagnosis and pharmaceutical management

AE M'Koma - Medical research archives, 2023 - ncbi.nlm.nih.gov
… as the understanding of the novel coronavirus progresses, IBD-specific … Management of
patient attending outpatient clinic with IBD in remission in the setting of asymptomatic SARS-CoV

[HTML][HTML] 12 Lessons learned from the management of the coronavirus pandemic

R Forman, R Atun, M McKee, E Mossialos - Health Policy, 2020 - Elsevier
… The Coronavirus SARS-CoV-2 has spread rapidly since the first cases hit Wuhan, China at
the end of 2019, and has now landed in almost every part of the world. By mid-February 2020…